CEO OF TERRAVIVE
Julianna Keeling is committed to developing innovative solutions that improve the lives of people and their environment. She is currently the Founder and CEO of Terravive, a global supplier of eco-friendly, sustainable and compostable consumable products. Since starting Terravive in 2015, she has built up a highly capable team to grow Terravive’s offerings from an academic idea to currently 72 different product lines that are now sold domestically and internationally in 4 continents. She has also grown Terravive’s operational capacity to 50 billion products across 16 different manufacturing facilities and distribution centers in the USA.
Julianna graduated from Washington & Lee University (W&L), where she studied Chemistry & Environmental Studies. She was awarded The Earle Bates Prize in Environmental Citizenship Award, which is chosen by core W&L faculty on the basis of academic performance and contributions to the community. At W&L, Julianna received the top prize at the annual Entrepreneurship Summit. She was also awarded the W&L Johnson Scholarship, a highly competitive merit based scholarship worth over $250k.
In 2019, Julianna was selected to speak at SXSW, the United States Composting Council, and Virginia’s SWAMfest annual conference. She has published her research in several academic journals and has been featured in publications like Forbes, the Washington Post, the Richmond Times Dispatch, American Innovation, Richmond Innovation, Bioplastics News, and Plastics. Julianna holds multiple patents on plant-based materials and finished products and her dream is a plastic-less future for everyone.
The letter underscores a critical point: any effective policy response must address the entire solar supply chain—from polysilicon to ingots, wafers, cells, and finished modules—rather than focusing on a single segment in isolation.
It’s the second month in a row now that the U.S. Senate Special Committee on Aging has taken up the question of our woeful generics supply chain. This time, however, Ranking Member Kirsten Gillibrand (D-NY), started the hearing off by touching on a key topic in pharmaceuticals: the cost equation can no longer override the quality equation.
To reduce the deficit in a durable way, the United States must do more than tariff goods. It must tariff the money.
The development of GTAP-USL economic model marks another step forward in our efforts to make the GTAP more realistic and a better predictor of the real-world effects of trade policies or trade shocks. It’s critical to build models that provide a better understanding of how policies impact people, families, racial groups, gender, cities and regions. There is still more work to be done.
